The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Mycobacterium avium in the Postgenomic Era
Open accessAbstract
SUMMARY: The past several years have witnessed an upsurge of genomic data pertaining to the Mycobacterium avium complex (MAC). Despite clear advances, problems with the detection of MAC persist, spanning the tests that can be used, samples required for their validation, and the use of appropriate nomenclature. Additionally, the amount of genomic variability documented to date greatly outstrips the functional understanding of epidemiologically different subsets of the organism. In this review, we discuss how postgenomic insights into the MAC have helped to clarify the relationships between MAC organisms, highlighting the distinction between environmental and pathogenic subsets of M. avium. We discuss the availability of various genetic targets for accurate classification of organisms and how these results provide a framework for future studies of MAC variability. The results of postgenomic M. avium study provide optimism that a functional understanding of these organisms will soon emerge, with genomically defined subsets that are epidemiologically distinct and possess different survival mechanisms for their various niches. Although the status quo has largely been to study different M. avium subsets in isolation, it is expected that attention to the similarities and differences between M. avium organisms will provide greater insight into their fundamental differences, including their propensity to cause disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847 · cited 1×
“tuberculosis H37Rv genome sequence (48, 152).”
Classification and Grading of Gastritis: The Updated Sydney System
Dixon, M. F., Genta, R. M., Yardley, J. H., & Correa, P. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00001 · Cited by 5,185
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Craig, H. (1957) · Geochimica et Cosmochimica Acta · doi:10.1016/0016-7037(57)90024-8 · Cited by 4,170 · cited 5×
“Alternative molecular detection methods such as loop-mediated isothermal amplification tests have also been used, although they are not in routine use (88, 173).”
BackgroundMethodInfluentialCraig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
ISfinder: the reference centre for bacterial insertion sequences
Siguier, P. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj014 · Cited by 2,767 · cited 1×
“Proper IS nomenclature (244) was eventually assigned to this element, now referred to as ISMav1 (ISFinder [http://www-is.”
Practice Guidelines for the Management of Bacterial Meningitis
Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004) · Clinical Infectious Diseases · doi:10.1086/425368 · Cited by 2,308
Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C., & Stover, C. K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.5.1274-1282.1996 · Cited by 1,103
Pym, A. S., Brodin, P., Brosch, R., Huerre, M., & Cole, S. T. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03237.x · Cited by 729
Deletion of RD1 from Mycobacterium tuberculosis Mimics Bacille Calmette‐Guérin Attenuation
Lewis, K. N., Liao, R., Guinn, K. M., Hickey, M. J., Smith, S., Behr, M. A., & Sherman, D. R. (2003) · The Journal of Infectious Diseases · doi:10.1086/345862 · Cited by 588
Self-citationSkin disease and socioeconomic conditions in rural Africa: Tanzania
GIBBS, S. (1996) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1996.tb03687.x · Cited by 225
Mutations in the 16S rRNA Genes of Helicobacter pylori Mediate Resistance to Tetracycline
Trieber, C. A., & Taylor, D. E. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.8.2131-2140.2002 · Cited by 174
Mycobactin, a growth factor for Mycobacterium johnei. 1. Isolation from Mycobacterium phlei
Francis, J., Macturk, H. M., Madinaveitia, J., & Snow, G. A. (1953) · Biochemical Journal · doi:10.1042/bj0550596 · Cited by 121 · cited 1×
“phlei (90, 173) which was subsequently replaced by mycobactin J, currently used today, obtained from a strain of M.”
Dailidiene, D., Bertoli, M. T., Miciuleviciene, J., Mukhopadhyay, A. K., Dailide, G., Pascasio, M. A., Kupcinskas, L., & Berg, D. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3940-3946.2002 · Cited by 101
Cited by
Opportunistic pathogens enriched in showerhead biofilms
Feazel, L. M., Baumgartner, L. K., Peterson, K. L., Frank, D. N., Harris, J. K., & Pace, N. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908446106 · Cited by 557
Brown-Elliott, B. A., Nash, K. A., & Wallace, R. J. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05030-11 · Cited by 541
Self-citationPractical Guidance for Clinical Microbiology Laboratories: Mycobacteria
Forbes, B. A., Hall, G. S., Miller, M. B., Novak, S. M., Rowlinson, M.-C., Salfinger, M., Somoskövi, A., Warshauer, D. M., & Wilson, M. L. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00038-17 · Cited by 311
Halaas, Ø., Steigedal, M., Haug, M., Awuh, J. A., Ryan, L., Brech, A., Sato, S., Husebye, H., Cangelosi, G. A., Akira, S., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/650493 · Cited by 68
“not receiving antiretroviral therapy [7].”
Metadata
- Authors
- Turenne, C. Y., Wallace, R., & Behr, M. A.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2007-04
- Volume
- 20
- Issue
- 2
- Pages
- 205-229
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2103289581
- Cited by
- 226
- References
- 14
- FWCI
- 13.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.